Loading organizations...
§ Venture Capital · Gent, Gelderland, The Netherlands
Venture capital fund in Belgium offers early-stage seed capital to commercialize academic research from Ghent University spin-offs.
Baekeland II Fund operated as a venture capital fund, providing early-stage and seed funding for high-tech start-ups. Its investment strategy centered on commercializing innovative research and intellectual property directly from the Ghent University Association ecosystem. The fund supplied crucial initial capital, facilitating scientific discoveries into viable market-ready enterprises.
Established in 2005, Baekeland II Fund was a strategic initiative by Ghent University and its partners, building upon Baekeland Fund I. The fundamental insight recognized a need for dedicated financial support for university spin-offs, bridging the gap between academic excellence and commercial viability. This allowed for targeted investment in research-driven projects.
The fund's portfolio comprised high-tech companies and spin-offs closely tied to Ghent University. Baekeland II Fund's ambition was to foster regional innovation and economic growth. Its vision focused on transforming academic advancements into successful commercial entities, enriching the local knowledge economy and securing societal impact.
Baekeland II Fund has 1 tracked investment across 1 company. The latest tracked deal is $15.6M Series B in Complix in June 2013.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 26, 2013 | Complix | $15.6M Series B | Biotech Fund Flanders, Patrick VAN Beneden | CRP Sant, Gemma Frisius Fund, LRM, Omnes Capital, Trustcapital, Vesalius Biocapital, Vinnof |